Psoriatic fibroblasts secrete lower amounts of IL-6 than healthy fibroblasts before and after stimulation with TNF-alpha.
Altered function of the fibroblasts is thought to contribute to the pathogenesis of psoriasis. To further elucidate this point, we compared the ability of fibroblasts from psoriatic lesions and of fibroblasts from healthy individuals to produce interleukin-6 (IL-6). The IL-6 levels were measured by ELISA in serum-free culture medium before and after stimulation of monolayer fibroblasts with various concentrations of tumour necrosis factor-alpha (TNF-alpha), platelet-derived growth factor (PDGF), and interferon-gamma (IFN-gamma), alone and in different combinations. The production of IL-6 in the fibroblast cultures was stimulated by TNF-alpha (0.01-10 nm/ml medium) in a dose-dependent way. Fibroblasts from psoriatic lesions produced lower amounts of IL-6 than fibroblasts from healthy individuals both before and after stimulation with the different concentrations of TNF-alpha (P = 0.012). The ratios between the IL-6 concentrations before and after stimulation with TNF-alpha were similar in both types of fibroblasts, indicating that the capacity to produce IL-6 is reduced in psoriatic fibroblasts compared with healthy ones. The production of IL-6 was not influenced by either PDGF or IFN-gamma. These findings support the view that the phenotype of the fibroblast is altered in psoriasis.
Fransson
J
J
Department of Dermatology, Karolinska Hospital, 171 76 Stockholm, Sweden.
de la Torre
B
B
Hammar
H
H
D000328:Adult; D002478:Cells, Cultured; D005260:Female; D005347:Fibroblasts / Q000378:metabolism*; D006801:Humans; D015850:Interleukin-6 / Q000378:metabolism*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000378:metabolism* / Q000473:pathology; D012016:Reference Values; D012867:Skin / Q000378:metabolism* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000494:pharmacology*
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha